September 2026 Research Update

This month added a clearer picture of what ALMS1 may be doing inside developing fat tissue, and the message was not uniform across the body. In mouse fat precursor cells, loss of ALMS1 blocked fat cell formation in visceral (deep abdominal) fat precursors, but not in subcutaneous (under-the-skin) fat precursors. This points to ALMS1 having a tissue-specific role, which may help explain why metabolic features can be complex in Alstrom syndrome. [1]

The study linked this difference to problems with primary cilia, which are small cell structures used for signaling. ALMS1-deficient visceral precursors had fewer or abnormal cilia and reduced centriole cohesion, and they did not respond normally to signaling steps that should happen after certain receptors reach the cilium. In plain terms, the cells seemed able to place some signaling receptors in the right location, but still could not pass the signal along to trigger normal fat-cell development. [1]

This evidence is laboratory research in mouse-derived cells, so it does not show how a person will do or predict what will work as a therapy. What it adds right now is a more specific biological explanation for how ALMS1 changes cell signaling, and why fat tissue in different body locations might not act the same way. What remains uncertain is whether the same visceral-versus-subcutaneous pattern happens in people with Alstrom syndrome, and how directly this connects to real-world issues like weight, insulin resistance, or fatty liver. [1]

This month also reported an early signal that Alstrom syndrome may have a distinct mouth microbiome and mouth-fluid chemistry pattern beyond what is seen in obesity alone. The study combined measurements of oral bacteria with broad chemical profiling of saliva and fluid from the gumline, and it found coordinated patterns that separated the ALMS/BBS group from obesity controls and healthy controls. The results were presented as exploratory and meant to generate hypotheses rather than prove cause and effect. [2]

On the bacteria side, the ALMS/BBS group showed higher levels of some taxa (including Prevotella, Enterococcus, and Eikenella) and lower levels of Lactobacillus compared with controls. On the chemistry side, the group showed differences in signals related to amino acids, fats, and carbohydrates, and the study reported that saliva and gum-fluid did not show the same interaction patterns with bacteria. In simple terms, the mouth environment looked altered in multiple connected ways, and different parts of the mouth seemed to carry different pieces of that pattern. [2]

This study may matter later if confirmed, because it hints that the mouth (bacteria and local metabolism) could reflect broader body metabolism in Alstrom syndrome, or potentially become a source of measurable markers. For now, it does not change diagnosis or care because it was small, cross-sectional, and included a combined ALMS/BBS group rather than Alstrom syndrome alone. What remains uncertain is whether these oral patterns track with symptoms or complications over time, and whether they are specific to Alstrom syndrome rather than related conditions or obesity. [2]